Private Equity

A training intensive promises to turn teachers into six-figure consultants. But behind the bold claims, some educators question the high-stakes business model.

The 28th Family Film & TV Awards, airing on CBS, will honor Jeff Probst and Penn & Teller, feature a Blake Shelton performance, and support Toys for Tots.

Millions struggle to swallow pills. Azurity's new FDA-approved liquid hypertension drug, Javadin, offers a ready-to-use solution for better adherence.

A new report reveals a shocking decline in Canadian public companies and IPOs, signaling economic stagnation and shutting out average investors.

Medical cannabis firm Crucial Innovations retains FOCUS Capital Partners, signaling a push for institutional investment and a potential 2026 US listing.

The 2025 Governors' Awards reveal how historic sites are being transformed into hubs for social housing, Reconciliation, and economic growth across Canada.

Syra Health appoints Gregory R. Alexander as CEO, banking on his military discipline and record of scaling healthcare firms to drive its next growth phase.

RPM's strategic acquisition of Dealers Choice Auto Transport signals a major shift, combining enterprise logistics tech with white-glove specialty service.

GOWell's breakthrough well tech gets a key nod in a Net Zero program, bolstering its case for a planned $401M Nasdaq debut via a SPAC merger.

Seafood giant Fortune International has acquired North Carolina's Simply Fresh, a move that consolidates the premium market and preserves a beloved local legacy.

A new partnership aims to power a tech boom in Southwest Virginia with a massive gas-fired plant, sparking hopes for revival and questions about energy.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Revelstoke Mountain Resort unveils new luxury homes, fueling its transformation into a year-round hub amid a local housing crunch and soaring demand.

Asia Pacific Wire & Cable is raising $33.9M via a rights offer to fund its US expansion. Shareholders must now weigh participation against dilution risk.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

Struggling Inno Holdings rolls the dice with a massive reverse stock split to avoid delisting, but grim financials and a brutal market reaction raise alarms.

With a massive potential loan, the U.S. government is backing a plan to mine in Alaska and manufacture in Ohio, aiming to end its reliance on foreign graphite.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?

Lincoln Gold secures $850k in a high-interest deal with its own chairman, funding Nevada projects but setting the stage for a shareholder vote on control.